Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 5 minute read Healthcare Industry News Insulet names Flavia Pease as new CFO while signaling stronger Q3 revenue growth momentum Insulet (NASDAQ: PODD) taps Flavia Pease as CFO and expects Q3 revenue growth to surpass guidance. Find out what this means for investors and the medtech sector. byPallavi MadhirajuSeptember 16, 2025